| TTM
|
12/31/2023
|
12/31/2022
|
12/31/2021
|
|
|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-10,490.8750 | -13,000.6240 | -15,934.4390 | -15,799.4320 |
|
Research and Development Expenses
|
-9,669.2440 | -19,282.2300 | -47,148.4500 | -37,456.3500 |
|
Operating Income/Expenses
|
-20,160.1190 | -32,282.8540 | -63,082.8890 | -53,255.7820 |
|
Total Operating Profit/Loss
|
-20,160.1190 | -32,282.8540 | -63,082.8890 | -53,255.7820 |
| Total Net Finance Income/Expense
|
246.9960 | 698.3950 | 664.3720 | -852.8150 |
| Net Investment Income
|
0 | -- | 0 | 2,424.8770 |
| Irregular Income/Expenses
|
-2,211.0430 | -690.7680 | 0 | 843.6190 |
|
Other Income/Expense, Non-Operating
|
12.7180 | -69.1660 | -87.6820 | -61.4070 |
|
Non-Operating Income/Expenses, Total
|
-456.7310 | -61.5390 | 576.6900 | 2,354.2740 |
|
Pretax Income
|
-20,616.8500 | -32,344.3930 | -62,506.1990 | -50,901.5080 |
|
Net Income from Continuing Operations
|
-20,616.8500 | -32,344.3930 | -62,506.1990 | -50,901.5080 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-20,616.8500 | -32,344.3930 | -62,506.1990 | -50,901.5080 |
|
Net Income after Non-Controlling/Minority Interests
|
-20,616.8500 | -32,344.3930 | -62,506.1990 | -50,901.5080 |
| Preferred/Other Stock Distribution
|
0 | -- | 0 | -377.5620 |
|
Net Income Available to Common Stockholders
|
-20,616.8500 | -32,344.3930 | -62,506.1990 | -51,279.0700 |
|
Diluted Net Income Available to Common Stockholders
|
-20,616.8500 | -32,344.3930 | -62,506.1990 | -51,279.0700 |
| Basic EPS
|
-18.50 | -30.82 | -64.95 | -63.50 |
| Diluted EPS
|
-18.50 | -30.82 | -64.95 | -63.50 |
|
Basic Weighted Average Shares Outstanding
|
1,185.6230 | 1,049.4680 | 962.3640 | 807.4450 |
|
Diluted Weighted Average Shares Outstanding
|
1,185.6230 | 1,049.4680 | 962.3640 | 807.4450 |
| Income Statement, Supplemental
|
||||
|
EBIT
|
-20,863.8460 | -33,042.7880 | -63,170.5710 | -50,048.6930 |
|
EBITDA
|
-20,179.4750 | -32,017.8150 | -62,175.7790 | -49,178.4080 |
|
Normalized EBITDA
|
-15,619.5420 | -27,773.4210 | -56,284.1510 | -46,458.6800 |
|
Normalized Income
|
-16,056.9170 | -28,099.9990 | -56,614.5710 | -48,181.7800 |
|
Total Unusual Items
|
4,559.9330 | 4,244.3940 | 5,891.6280 | 2,719.7280 |
|
Total Unusual Items Excluding Goodwill
|
4,559.9330 | 4,244.3940 | 5,891.6280 | 2,719.7280 |
|
Tax Effect of Unusual Items
|
0 | 0 | 0 | 0 |
|
Tax Rate, Calculated
|
0.00 | 0.00 | 0.00 | 0.00 |
12/31/2021 - 2/12/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade